Apollo Endosurgery Inc (NASDAQ: APEN) announced the marketing authorization of the Apollo ESG, Apollo ESG Sx, Apollo REVISE, and Apollo REVISE Sx Systems through the FDA De Novo Classification ...

Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced today that the MERIT trial ...

NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) — Apollo Global Management, Inc. (NYSE: APO) (together with its consolidated subsidiaries, “Apollo”) today published its 13 th annual ESG report, Driving a ...

Boston Scientific: The launched technology Apollo ESG System is authorised by both US FDA and CDSCO while, Orbera365 System is indicated by CDSCO for temporary usage on those obese patients (BMI ...